Smoking is associated with a high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-SEARCH
- 11 July 2010
- journal article
- research article
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 99 (12) , 825-832
Abstract
Microalbuminuria (MAU) is a marker of endothelial dysfunction and a predictor of cardiovascular events. The effects of cigarette smoking on the prevalence of MAU in a high-risk population with arterial hypertension are unclear.Keywords
This publication has 27 references indexed in Scilit:
- Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patientsEuropean Heart Journal, 2009
- Influence of Albuminuria on Cardiovascular Risk in Patients With Stable Coronary Artery DiseaseCirculation, 2007
- Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global studyJournal Of Hypertension, 2007
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspectiveKidney International, 2006
- The renal risks of smokingKidney International, 1997
- Proteinuria and Mortality in Diabetes: the WHO Multinational Study of Vascular Disease in DiabetesDiabetic Medicine, 1995
- Relationship of Smoking and Albuminuria in Children with Insulin‐dependent DiabetesDiabetic Medicine, 1994
- Microalbuminuria and endothelial dysfunction in essential hypertensionThe Lancet, 1994
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976